Marginal Zone Lymphoma — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for marginal zone lymphoma. 460 active patents protecting 2 drugs from 2+ originators. First major cliff: 2026. Daily refresh.

2
Approved drugs
460
Active US patents
49/100
Avg vulnerability
$9.0B
Annual revenue covered

Originators in Marginal Zone Lymphoma

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

AbbVie 448 patents Bristol-Myers Squibb 12 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating marginal zone lymphoma. Each bar = one year. Y-axis scaled to peak year (117 patents).

70
26
93
27
13
28
117
31
81
33
30
34
19
35
36
36
1
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Imbruvica
ibrutinib
 AbbVie 448 43 $3.2B 2026-12-28
Revlimid
lenalidomide
 Bristol-Myers Squibb 12 54 $5.8B 2027-04-27

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8741929 Revlimid method of use 80 2028-03-08
8741929 Revlimid method of use 80 2028-03-08
8741929 Revlimid method of use 80 2028-03-08
8741929 Revlimid method of use 80 2028-03-08
8741929 Revlimid method of use 80 2028-03-08
8741929 Revlimid method of use 80 2028-03-08
8703780 Imbruvica method of use 76 2026-12-28
8952015 Imbruvica method of use 76 2026-12-28
8476284 Imbruvica method of use 76 2026-12-28
8563563 Imbruvica method of use 76 2027-04-26

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9296753 Imbruvica composition of matter 0 2033-10-30
9296753 Imbruvica composition of matter 0 2033-10-30
9296753 Imbruvica composition of matter 0 2033-10-30
9296753 Imbruvica composition of matter 0 2033-10-30
9296753 Imbruvica composition of matter 0 2033-10-30
9296753 Imbruvica composition of matter 0 2033-10-30
9296753 Imbruvica composition of matter 0 2033-10-30
10125140 Imbruvica composition of matter 0 2033-06-03
10106548 Imbruvica composition of matter 0 2033-06-03
10106548 Imbruvica composition of matter 0 2033-06-03

Related